Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Bluebird bio Inc
BLUECurrent price
1.22 USD
-0.03 USD (-2.40%)
Last closed
1.15 USD
Company
www.bluebirdbio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
202 379 088 USD
Yield for 12 month
-67.29 %
1Y
3Y
5Y
10Y
15Y
BLUE
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts. Address: 455 Grand Union Boulevard, Somerville, MA, United States, 02145
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.57 USDP/E ratio
–Dividend Yield
–Current Year
+21 726 000 USD
Last Year
+3 597 000 USD
Current Quarter
+12 392 000 USD
Last Quarter
+6 890 000 USD
Current Year
-2 190 000 USD
Last Year
-6 480 000 USD
Current Quarter
+1 437 000 USD
Last Quarter
-2 674 000 USD
Key Figures BLUE
1 year
3 years
5 years
10 years
EBITDA
-131 774 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-15.01 %
PEG Ratio
0.32
Return On Equity TTM
-47.81 %
Wall Street Target Price
3.57 USD
Revenue TTM
21 726 000 USD
Book Value
2.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
17353.5 %
Dividend Yield
–
Gross Profit TTM
-247 244 000 USD
Earnings per share
-0.63 USD
Diluted Eps TTM
-0.63 USD
Most Recent Quarter
III 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics BLUE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1544:1000
Payout Ratio
–
Last Split Date
05.11.2021
Dividend Date
–
Stock Valuation BLUE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
15.8022
Price Sales TTM
9.7586
Enterprise Value EBITDA
-2.6054
Price Book MRQ
0.9612
Financials BLUE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators BLUE
For 52 weeks
0.85 USD
5.53 USD
50 Day MA
1 USD
Shares Short Prior Month
29 475 366
200 Day MA
1.66 USD
Short Ratio
4.72
Shares Short
30 713 131
Short Percent
17.02 %
BeatStart